Login
$EMBC
$6.25 -$0.21 (3.25%) Live

Company Executives

Officer Age 2025 pay Source
Devdatt (Dev) Kurdikar Also a director
President and CEO
Title from the Form 4 dated Aug 12, 2026
57 $9,400,088
Jacob (Jake) Elguicze
Senior Vice President and Chief Financial Officer
52 $3,459,049
Jean Casner
Senior Vice President and Chief Human Resources Officer
67 $1,729,993
Jeff Mann
Pres, Pharm Svc&Prod Mgmt, CLO
Title from the Form 4 dated Aug 12, 2026
53 $3,005,372
Anthony Roth
Vice President, Chief Accounting Officer and Corporate Controller
52 Not reported
Tom Blount
Senior Vice President and President, North America
52 Not reported
Slobodan Radumilo
Senior Vice President and President, International
55 Not reported
Ginny Blocki
Senior Vice President, Strategy
Not stated Not reported
Shaun Curtis
Senior Vice President, Global Manufacturing, Supply Chain and Quality
56 $2,065,037

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
3.0 years
from year joined
Director Age On board Independent Committees Other public boards 2025 pay Source
Devdatt (Dev) Kurdikar
57 2022
3 years
Not independent None stated Zimmer Biomet Holdings, Inc. Paid as CEO
Carrie L. Anderson
57 2022
3 years
Independent
Audit Corporate Governance and Nominating
None stated $317,004
Robert (Bob) J. Hombach
59 2022
3 years
Independent
Audit · Chair Compensation and Management Development Committee
BioMarin Pharmaceutical Inc., Henry Schein, Inc. $332,004
Milton M. Morris
55 2022
3 years
Independent
Compensation and Management Development Technology, Quality and Regulatory
Myomo, Inc. $317,004
Claire Pomeroy
70 2022
3 years
Independent
Corporate Governance and Nominating · Chair
Haemonetics Corporation $333,004
Karen N. Prange
61 2022
3 years
Independent
Corporate Governance and Nominating
AtriCure, Inc. $328,004
Christopher R. Reidy
69 2022
3 years
Independent
Technology, Quality and Regulatory · Chair Audit
None stated $331,754

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Dec 18, 2025 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support